FOXN3 Downregulation in Colorectal Cancer Enhances Tumor Cell Stemness by Promoting EP300‐Mediated Epigenetic Upregulation of SOX12
Molecular Carcinogenesis · 2025
DOI: 10.1002/mc.23852 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Carcinogenesis, 2025. Verfasst von Yanjie Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Third Affiliated Hospital of Soochow University, Changzhou, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, E1A-Associated p300 Protein, Gene Expression Regulation, Neoplastic, SOXC Transcription Factors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: This work was supported by the Major Science and Technology Projects of Changzhou City (ZD202107), Changzhou "14th Five-Year Plan" High-level Health Personnel….
Abstract (Originalsprache)
Cancer stemness plays a crucial role in promoting the progression of colorectal cancer (CRC). Forkhead box N3 (FOXN3) is a tumor suppressor protein. Herein, we investigated the role of FOXN3 in the regulation of CRC cell stemness. Cell viability, proliferation, migration, and invasion were assessed utilizing cell counting kit‐8 assay, 5‐ethynyl‐20‐deoxyuridine assay, and Transwell assay, respectively. Cell‐sphere formation was assessed using a sphere‐forming assay. The enrichment of H3K27ac modifications at the SRY‐related HMG‐box 12 (SOX12) promoter, interactions among FOXN3, SOX12, and E1A binding protein p300 (EP300) were analyzed using chromatin immunoprecipitation or dual luciferase reporter assays. We found that FOXN3 overexpression inhibited CRC cell proliferation, migration, invasion, stemness, and tumor formation in mice by inactivating the Wnt/β‐catenin signaling, while these effects of FOXN3 overexpression were reversed by the overexpression of SOX12. Mechanistically, EP300 increased SOX12 expression in CRC cells by promoting H3K27ac enrichment in the SOX12 promoter. In addition, FOXN3 transcriptionally inhibited EP300 expression in CRC cells by binding to the EP300 promoter. As expected, EP300 overexpression weakened the inhibitory effect of FOXN3 overexpression on CRC cell stemness. Collectively, FOXN3 upregulation inhibited CRC cell stemness by suppressing EP300‐mediated epigenetic upregulation of SOX12.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, The Third Affiliated Hospital of Soochow University, Changzhou, China.
- Department of Gastrointestinal Surgery, The First People's Hospital of Changzhou, The Third Affiliated Hospital of Soochow University, Changzhou, China.
Förderung
- This work was supported by the Major Science and Technology Projects of Changzhou City (ZD202107), Changzhou "14th Five-Year Plan" High-level Health Personnel…
Zitieren
APA
Xu, Y., Xie, K., Li, L., Li, Z., Lu, Q., & Feng, J. (2025). FOXN3 Downregulation in Colorectal Cancer Enhances Tumor Cell Stemness by Promoting EP300‐Mediated Epigenetic Upregulation of SOX12. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23852
Vancouver
Xu Y, Xie K, Li L, Li Z, Lu Q, Feng J. FOXN3 Downregulation in Colorectal Cancer Enhances Tumor Cell Stemness by Promoting EP300‐Mediated Epigenetic Upregulation of SOX12. Molecular Carcinogenesis. 2025. doi:10.1002/mc.23852
BibTeX
@article{Xu2025,
author = {Xu, Yanjie and Xie, Ke and Li, Ling and Li, Zhong and Lu, Qicheng and Feng, Jin},
title = {FOXN3 Downregulation in Colorectal Cancer Enhances Tumor Cell Stemness by Promoting EP300‐Mediated Epigenetic Upregulation of SOX12},
journal = {Molecular Carcinogenesis},
year = {2025},
doi = {10.1002/mc.23852}
}
EUVIMED